AHRQ Health IT Update: Decision Supports for HPV Vaccine

AHRQ Health IT Update: Decision Supports for HPV Vaccine

AHRQ Health IT Update: Decision Supports for HPV Vaccine

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 05/16/2013 09:00 AM EDT

Providing families and clinicians with information to support decisions about starting and completing the human papillomavirus (HPV) vaccine series increases appropriate use of the vaccine. The HPV vaccine is effective in preventing some types of cervical cancer and requires a total of three shots given over six months. A study supported by the Agency for Healthcare Research and Quality evaluated the impact of education and electronic alerts on vaccination rates. Electronic alerts for clinicians were most likely to impact delivery of the first shot, while education and reminders for families were tied to receipt of shots two and three.

“The Implementation and Acceptability of an HPV Vaccination Decision Support System Directed at Both Clinicians and Families,” appeared in the 2012 AMIA Annual Symposium Proceedings.

Select to access this abstract: http://www.ncbi.nlm.nih.gov/pubmed/23304334.

“Effectiveness of Decision Support for Families, Clinicians, or Both on HPV Vaccine Receipt” appeared in the May issue of Pediatrics.

Select to access this abstract: http://www.ncbi.nlm.nih.gov/pubmed/23650297.